Published in Biochem J on August 01, 1973
FEEDBACK INHIBITION OF URIDINE KINASE BY CYTIDINE TRIPHOSPHATE AND URIDINE TRIPHOSPHATE. Biochim Biophys Acta (1964) 1.47
FREE RIBOSOMES DURING MATURATION OF RAT LIVER. Comp Biochem Physiol (1963) 1.46
Properties of thymidine kinase partially purified from human fetal and adult tissue. J Biol Chem (1972) 1.26
Studies on resistance against 5-fluorouracil. I. Enzymes of the uracil pathway during development of resistance. Cancer Res (1962) 1.20
Multiple forms of uridine kinase in normal and neoplastic rat liver. Biochem J (1971) 0.99
Regulation of enzymic activity by metabolites. I. Uridine-cytidine kinase of Novikoff ascites rat tumor. J Biol Chem (1969) 0.93
Cerebral cortex of the mouse after prenatal chemical insult. Am J Anat (1971) 0.90
Association of decreased uridine and deoxycytidine kinase with enhanced RNA and DNA polymerase in mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. Cancer Res (1970) 0.88
STUDIES ON RESISTANCE AGAINST 5-FLUOROURACIL. IV. EVIDENCE FOR AN ALTERED URIDINE KINASE IN RESISTANT CELLS. Biochim Biophys Acta (1963) 0.88
Alterations in pyrimidine metabolism in L5178Y leukemia cells resistant to 6-azauridine. Cancer Res (1961) 0.85
Enhanced stability of uridine kinase from mouse leukemic cells resistant to 5-azacytidine. Thermal inactivation and effect of p-chloromercuribenzoate. Eur J Biochem (1971) 0.84
Activity and distribution of the enzymes of uridylate synthesis from orotate in animal tissues. Biochim Biophys Acta (1972) 0.84
The presence of "fetal" thymidine kinase in human tumors. Biochim Biophys Acta (1972) 0.82
Enhanced uridine kinase and RNA synthesis in regenerating rat liver after 5-azacytidine administration. Arch Biochem Biophys (1972) 0.81
Enhanced uridine kinase in rat liver following 5-azacytidine administration. In vivo characterization and properties of partially purified enzyme. J Biol Chem (1973) 0.80
Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice. Cancer Res (1970) 0.79
Partial reversal of toxic effects of 5-azacytidine by 6-azauridine in normal mice. Experientia (1965) 0.78
5-Azacytidine, a new, highly effective cancerostatic. Experientia (1964) 1.84
Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Res (1990) 1.57
Biological effects of 5-azacytidine in eukaryotes. Oncology (1974) 1.54
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem (1997) 1.28
Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Cancer Res (1977) 1.01
Effect of 5-aza-2'-deoxycytidine against leukemic and hemopoietic tissues in AKR mice. Neoplasma (1968) 0.96
Characteristics of mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. Cancer Res (1968) 0.93
Azapyrimidine nucleosides: metabolism and inhibitory mechanisms. Adv Enzyme Regul (1985) 0.93
Mode of action and effects of 5-azacytidine and of its derivatives in eukaryotic cells. Pharmacol Ther (1985) 0.92
Association of decreased uridine and deoxycytidine kinase with enhanced RNA and DNA polymerase in mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. Cancer Res (1970) 0.88
Prolongation of the lag period preceding the enhancement of thymidine and thymidylate kinase activity in regenerating rat liver by 5-azacytidine. Biochem Pharmacol (1972) 0.87
Resonance properties of the vocal folds: in vivo laryngoscopic investigation of the externally excited laryngeal vibrations. J Acoust Soc Am (2000) 0.86
Phosphorylation of acyclic nucleotide analogs HPMPA and PMEA in L1210 mouse leukemia cell extracts. Neoplasma (1990) 0.86
Characterization of polyribosomes and maturation of ribosomal RNA in hepatoma cells treated with 5-azacytidine. Cancer Res (1974) 0.85
Enhanced stability of uridine kinase from mouse leukemic cells resistant to 5-azacytidine. Thermal inactivation and effect of p-chloromercuribenzoate. Eur J Biochem (1971) 0.84
Biochemical mechanisms of drug resistance. IV. Development of resistance to 5-azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice. Int J Cancer (1967) 0.84
Decreased synthesis of DNA in regenerating rat liver after the administration of reserpine. Br J Pharmacol (1973) 0.84
Synthesis of DNA in the liver and testes of cadmium-tested partially hepatectomized rats. J Biochem (1979) 0.83
Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine. Biochim Biophys Acta (1965) 0.82
The effect of blood around a flap pedicle on flap perfusion in an experimental rodent model. Acta Chir Plast (2009) 0.82
Synergistic effect of cis-dichlorodiammineplatinum and 5-aza-2'-deoxycytidine on mouse leukemic cells in vivo and in vitro. Int J Cancer (1982) 0.81
Enzymes relevant to cancer chemotherapy II. Heterogeneity of rat kidney uridine kinase following chromatography on Sepharose 6B coupled to N4-(5-amino-Pentyl)-cytidine. Neoplasma (1977) 0.80
Cleft palate repair by Furlow double-reversing Z-plasty: first speech results at the age of 6 years. Acta Chir Plast (2000) 0.80
Effects of 5-azacytidine on hepatic polyribosomes and maturation of ribosomal RNA. Acta Biol Med Ger (1974) 0.80
Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. Adv Exp Med Biol (1999) 0.80
Enhanced uridine kinase in rat liver following 5-azacytidine administration. In vivo characterization and properties of partially purified enzyme. J Biol Chem (1973) 0.80
History of upper extremity replantation in the Czech Republic and worldwide. Acta Chir Plast (2004) 0.79
Uridine kinase: properties, biological significance and chemotherapeutic aspects (a review). Neoplasma (1976) 0.79
5-azacytidine in childhood leukemia. Neoplasma (1971) 0.78
Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo. Cancer Res (1984) 0.78
Effect of 5-azacytidine and 6-azauridine on the synthesis of DNA in embryonic mouse brain mitotic activity and migration of ventricular cells. Neoplasma (1973) 0.78
Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells. Cancer Res (1979) 0.78
Cell suspensions, cell cultures, and tissue slices--important metabolic in vitro systems. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2001) 0.78
Partial reversal of toxic effects of 5-azacytidine by 6-azauridine in normal mice. Experientia (1965) 0.78
Inhibitory effect of various cytostatics and cycloheximide on acute experimental pancreatitis in rats. Gut (1977) 0.77
[Treatment of congenital pseudarthrosis of tibia by vascularized fibular graft]. Acta Chir Orthop Traumatol Cech (2006) 0.77
Tumor necrosis factor alpha in various tissues of insulin-resistant obese Koletsky rats: relations to insulin receptor characteristics. Physiol Res (1999) 0.77
Effect of 5-azacytidine on developing mouse embryo. Experientia (1968) 0.77
In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route. Drug Metab Dispos (2001) 0.77
Resistance of mammalian tumour cells toward pyrimidine analogues. A review. Oncology (1973) 0.77
5-Aza-2'-deoxycytidine: preclinical studies in mice. Neoplasma (1980) 0.77
[Sjogren's syndrome with paraproteinemia and hyperglobulinemic purpura]. Vnitr Lek (1967) 0.77
Enhanced DNA-dependent RNA polymerase and RNA synthesis in rat liver nuclei after administration of L-tryptophan. Biochim Biophys Acta (1970) 0.77
Metabolic transformations of 5-azaorotate: cause of marked inhibition of orotidine-5'-phosphate decarboxylase. Biochim Biophys Acta (1967) 0.77
Metabolic alterations of liver regeneration. 8. Enhanced synthesis of DNA in the liver of 5-azacytidine-treated rats subjected to partial hepatectomy. Int J Cancer (1972) 0.77
Preparation and biological activity of 5,6-dihydro-5-azapyrimidine nucleosides. Nucleic Acids Symp Ser (1987) 0.77
Impaired gastric secretion in rats treated with 5-azacytidine. Arch Int Pharmacodyn Ther (1974) 0.77
The use of medicinal leeches in fingertip replantation without venous anastomosis - case report of a 4-year-old patient. Acta Chir Plast (2014) 0.77
[Surgical treatment of endocrine orbital disease. Indications, methods,results]. Vnitr Lek (1992) 0.76
[Possibilities for the clinical use of 5-azacytidine]. Vopr Onkol (1977) 0.76
[The presence of human papillomavirus deoxyribonucleic acid in tumors in the otorhinolaryngologic area]. Cas Lek Cesk (1990) 0.76
[Immunomodulation of recurrent urinary tract infections with Urvakol vaccine]. Bratisl Lek Listy (1999) 0.76
Biochemical mechanism of drug resistance. VII. Inhibition of orotic acid metabolism by 5-azacytidine in leukemic mice sensitive and resistant to 5-azacytidine. Biochem Pharmacol (1968) 0.76
The efficacy of magnesium sulfate on resolving surgically provoked vasospasm of the flap pedicle in an experiment. Acta Chir Plast (2009) 0.76
The role of putrescine in modulation of DNA synthesis in regenerating liver of rats pretreated with 5-azacytidine. J Biochem (1981) 0.76
Transient aplastic crisis in a leukemic child caused by parvovirus B19 infection. Pediatr Hematol Oncol (1996) 0.76
Dehydroepiandrosterone effects on the mRNA levels of peroxisome proliferator-activated receptors and their coactivators in human hepatoma HepG2 cells. Gen Physiol Biophys (2007) 0.76
An objective evaluation of contraction power of neo-phallus reconstructed with free re-innervated LD in female-to-male transsexuals. Acta Chir Plast (2007) 0.76
In vitro glycosidation potential towards olomoucine-type cyclin-dependent kinase inhibitors in rodent and primate microsomes. Physiol Res (2003) 0.76
High-frequency induction in vivo of mouse leukemia in AKR strain by 5-azacytidine and 5-iodo-2'-deoxyuridine. Experientia (1973) 0.76
Neo-phalloplasty with re-innervated latissimus dorsi free flap: a functional study of a novel technique. Acta Chir Plast (2007) 0.75
Depressed synthesis of DNA in regenerating rat liver after spinal cord (C7) transection. Experientia (1973) 0.75
Effect of 5-azacytidine and its derivatives on gastric secretion. Pharmacol Ther (1985) 0.75
Thymidine kinase and polyribosome distribution in regerating rat liver following 5-azacytidine. Biochim Biophys Acta (1968) 0.75
L-Tryptophan action on hepatic RNA synthesis and enzyme induction. Mol Cell Biochem (1979) 0.75
Biotransformation and some metabolic effects of 5-(4-aminophenyl)-cytosine. Biochem Pharmacol (1967) 0.75
Transformation of 5-aza-2'-deoxycytidine-3H and its incorporation in different systems of rapidly proliferating cells. Eur J Cancer (1978) 0.75
Depression of DNA synthesis in mouse spleen after treatment with 5-aza-2'-deoxycytidine. J Natl Cancer Inst (1979) 0.75
Radioprotective effect of 5-azacytidine in AKR mice. Z Naturforsch B (1969) 0.75
[Participation of toxoplasmosis in the etiology of chronic tonsillitis (author's transl)]. Bratisl Lek Listy (1977) 0.75
Inhibitory effect of cycloheximide on gastric secretion in rats. Biochem Pharmacol (1977) 0.75
Metabolic alterations of liver regeneration. XV. Cadmium-mediated depression of thymidine and thymidylate kinase induction in rats. Chem Biol Interact (1979) 0.75
Stimulatory effect of 5-azacytidine on 7S antibody production on rats. Proc Soc Exp Biol Med (1978) 0.75
Lower gastric secretion and higher incorporation of orotic acid into liver RNA in rats treated with 5-azacytidine and cycloheximide. Neoplasma (1978) 0.75
Labeling of cytoplasmic liver RNA by (6- 14 C)orotic and 5-fluoro(2- 14 C)orotic acids. Effect of several inhibitors. Eur J Biochem (1973) 0.75
[5-azacytidine and new formation of purine nucleotides, RNA, proteins, and lipids in the cerebral cortex of guinea pigs (author's transl)]. Bratisl Lek Listy (1979) 0.75
Biochemical mechanisms of drug resistance. XII. Uridine kinases from mouse leukemic cells sensitive and resistant to 5-azacytidine. Int J Cancer (1971) 0.75
Effects of 5-aza-2'-deoxycytidine on DNA synthesis in mouse lymphatic tissues. Neoplasma (1978) 0.75
[Skin fistuals of dental origin]. Rozhl Chir (1969) 0.75
[Effect of some cytostatics and cycloheximide on the activity of pancreatic enzymes in the experiment on rats (author's transl)]. Sb Lek (1978) 0.75
Transformation of 5-aza-2'-(3H)deoxycytidine in Escherichia coli. FEBS Lett (1977) 0.75
[Clinical experience with prevention of isoimmunization by means of IgC gamma globulin]. Cesk Gynekol (1971) 0.75
Effects of 5-azacytidine on dietary and hormone induction of serine dehydratase and tyrosine aminotransferase in rat liver. Biochem Pharmacol (1972) 0.75
Effects of cycloheximide and streptovitacin A on protein synthesis and gastric secretion in rats. J Antibiot (Tokyo) (1978) 0.75